Durvalumab in Combination with Chemoradiotherapy for Patients with Unresectable Stage III Non-Small-cell Lung Cancer: Results from the Phase 1 CLOVER Study
Lung Cancer(2024)
关键词
Durvalumab,Unresectable,Stage III NSCLC,Concurrent chemoradiotherapy,Phase 1 study
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要